RecruitingNCT05327023
Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
PHASE1 · PHASE2 · 430 planned enrolment
- Countries listed
- 1
- Registry update
- September 18, 2026
Source-linked trial list
The registrations behind this number.
Verify the exact trial registrations behind a company, intervention, programme or topic count.
Exact trial list
4 matching trial registrations
- Intervention Busulfan
Showing 1–4 of 4. Every record below meets all the filters shown above.
Enrolling By InvitationNCT07113743
Part B- G1X-CGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease
PHASE1 · PHASE2 · 10 planned enrolment
- Countries listed
- 1
- Registry update
- September 8, 2026
RecruitingNCT06325709
Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease
PHASE1 · PHASE2 · 15 planned enrolment
- Countries listed
- 1
- Registry update
- August 13, 2026
WithdrawnNCT05170828
Cryopreserved MMUD BM With PTCy for Hematologic Malignancies
PHASE1 · 0 planned enrolment
- Countries listed
- 0
- Registry update
- February 24, 2026